Group: Advisors
Chris D. Brown, PhD
Co-Founder & CTO, 908 Devices
William Cantley, PhD
Senior Scientist, CNS Biology, Alnylam Pharmaceuticals
Michael Cuccarese, PhD
Senior Director, Oncology and industrialized drug discovery, Recursion, Inc
Konstantinos Gkatzis, PhD
Expert in cardiac and neuronal drug development programs, safety assessment (KSILINK, Myrtil Biosciences)
Keith James, PhD
Retired. Former SVP Drug Discovery Insitro, Previous executive positions with Ferring Pharmaceuticals & Pfizer
Lincoln Muir
Retired. Former Director of Commercial, North America Agilent Technologies (ACEA Biosciences)
Jerrold R. Turner, MD, PhD
Professor of Pathology & Medicine, Harvard Medical School Physician-scientist
Vladislav Zarayskiy, PhD
Director of Automation & Screening Technologies, Monte Rosa Therapeutics